Annual CFO:
$4.42B-$173.50M(-3.78%)Summary
- As of today, REGN annual cash from operations is $4.42 billion, with the most recent change of -$173.50 million (-3.78%) on December 31, 2024.
- During the last 3 years, REGN annual cash from operations has fallen by -$2.66 billion (-37.58%).
- REGN annual cash from operations is now -37.58% below its all-time high of $7.08 billion, reached on December 31, 2021.
Performance
REGN Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly CFO:
$1.14B+$99.30M(+9.50%)Summary
- As of today, REGN quarterly cash from operations is $1.14 billion, with the most recent change of +$99.30 million (+9.50%) on June 30, 2025.
- Over the past year, REGN quarterly cash from operations has increased by +$790.40 million (+223.28%).
- REGN quarterly cash from operations is now -66.48% below its all-time high of $3.41 billion, reached on September 30, 2021.
Performance
REGN Quarterly Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFO:
$4.74B+$790.40M(+19.99%)Summary
- As of today, REGN TTM cash from operations is $4.74 billion, with the most recent change of +$790.40 million (+19.99%) on June 30, 2025.
- Over the past year, REGN TTM cash from operations has increased by +$673.00 million (+16.53%).
- REGN TTM cash from operations is now -44.29% below its all-time high of $8.51 billion, reached on March 31, 2022.
Performance
REGN TTM Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
REGN Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -3.8% | +223.3% | +16.5% |
| 3Y3 Years | -37.6% | +102.8% | -43.9% |
| 5Y5 Years | +81.9% | +21.3% | +118.1% |
REGN Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -37.6% | at low | -33.5% | +223.3% | -16.3% | +20.0% |
| 5Y | 5-Year | -37.6% | +81.9% | -66.5% | +550.0% | -44.3% | +118.1% |
| All-Time | All-Time | -37.6% | +3220.0% | -66.5% | +550.0% | -44.3% | +1907.3% |
REGN Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $1.14B(+9.5%) | $4.74B(+20.0%) |
| Mar 2025 | - | $1.05B(-17.2%) | $3.95B(-10.6%) |
| Dec 2024 | $4.42B(-3.8%) | $1.26B(-2.2%) | $4.42B(+4.1%) |
| Sep 2024 | - | $1.29B(+264.7%) | $4.25B(+4.3%) |
| Jun 2024 | - | $354.00M(-76.6%) | $4.07B(-14.1%) |
| Mar 2024 | - | $1.51B(+38.8%) | $4.74B(+3.2%) |
| Dec 2023 | $4.59B(-8.4%) | $1.09B(-2.2%) | $4.59B(-12.1%) |
| Sep 2023 | - | $1.11B(+9.0%) | $5.22B(+10.2%) |
| Jun 2023 | - | $1.02B(-25.2%) | $4.74B(+10.7%) |
| Mar 2023 | - | $1.37B(-20.5%) | $4.28B(-14.6%) |
| Dec 2022 | $5.01B(-29.2%) | $1.72B(+173.5%) | $5.01B(-11.5%) |
| Sep 2022 | - | $628.90M(+11.4%) | $5.67B(-32.9%) |
| Jun 2022 | - | $564.40M(-73.1%) | $8.45B(-0.7%) |
| Mar 2022 | - | $2.10B(-11.4%) | $8.51B(+20.2%) |
| Dec 2021 | $7.08B(+170.5%) | $2.37B(-30.5%) | $7.08B(+19.2%) |
| Sep 2021 | - | $3.41B(+444.7%) | $5.94B(+161.4%) |
| Jun 2021 | - | $626.70M(-6.3%) | $2.27B(-12.2%) |
| Mar 2021 | - | $668.50M(-45.7%) | $2.59B(-1.1%) |
| Dec 2020 | $2.62B(+7.7%) | $1.23B(+584.1%) | $2.62B(+20.4%) |
| Sep 2020 | - | -$254.30M(-127.0%) | $2.17B(-27.2%) |
| Jun 2020 | - | $943.40M(+35.2%) | $2.99B(+33.8%) |
| Mar 2020 | - | $698.00M(-11.4%) | $2.23B(-8.2%) |
| Dec 2019 | $2.43B(+10.7%) | $787.40M(+41.3%) | $2.43B(+2.5%) |
| Sep 2019 | - | $557.30M(+196.0%) | $2.37B(+4.6%) |
| Jun 2019 | - | $188.30M(-79.0%) | $2.27B(-8.3%) |
| Mar 2019 | - | $897.00M(+23.1%) | $2.47B(+12.7%) |
| Dec 2018 | $2.20B(+67.9%) | $728.83M(+60.9%) | $2.20B(+8.0%) |
| Sep 2018 | - | $452.96M(+14.8%) | $2.03B(+1.9%) |
| Jun 2018 | - | $394.56M(-36.2%) | $2.00B(+27.1%) |
| Mar 2018 | - | $618.74M(+9.1%) | $1.57B(+20.1%) |
| Dec 2017 | $1.31B(-11.3%) | $566.95M(+36.7%) | $1.31B(+16.9%) |
| Sep 2017 | - | $414.83M(+1457.0%) | $1.12B(-17.4%) |
| Jun 2017 | - | -$30.57M(-108.6%) | $1.35B(-24.1%) |
| Mar 2017 | - | $355.90M(-5.8%) | $1.78B(+21.1%) |
| Dec 2016 | $1.47B(+10.7%) | $377.88M(-42.0%) | $1.47B(+7.0%) |
| Sep 2016 | - | $651.03M(+63.0%) | $1.38B(-14.9%) |
| Jun 2016 | - | $399.50M(+788.0%) | $1.62B(+10.7%) |
| Mar 2016 | - | $44.99M(-84.0%) | $1.46B(+10.0%) |
| Dec 2015 | $1.33B(+79.1%) | $281.82M(-68.4%) | $1.33B(+6.7%) |
| Sep 2015 | - | $892.85M(+266.5%) | $1.25B(+140.8%) |
| Jun 2015 | - | $243.61M(+378.4%) | $517.94M(-14.0%) |
| Mar 2015 | - | -$87.50M(-144.1%) | $602.13M(-19.0%) |
| Dec 2014 | $743.16M(+27.3%) | $198.28M(+21.2%) | $743.16M(-9.6%) |
| Sep 2014 | - | $163.56M(-50.1%) | $821.65M(+9.5%) |
| Jun 2014 | - | $327.79M(+512.4%) | $750.55M(+36.2%) |
| Mar 2014 | - | $53.53M(-80.7%) | $550.93M(-5.6%) |
| Dec 2013 | $583.65M(+882.2%) | $276.78M(+199.4%) | $583.65M(+45.9%) |
| Sep 2013 | - | $92.45M(-27.9%) | $400.05M(+31.1%) |
| Jun 2013 | - | $128.16M(+48.6%) | $305.21M(+209.3%) |
| Mar 2013 | - | $86.25M(-7.4%) | $98.67M(+232.2%) |
| Dec 2012 | -$74.61M(+47.3%) | $93.19M(+4012.0%) | -$74.61M(+65.8%) |
| Sep 2012 | - | -$2.38M(+97.0%) | -$218.12M(+16.9%) |
| Jun 2012 | - | -$78.38M(+10.0%) | -$262.47M(-20.3%) |
| Mar 2012 | - | -$87.04M(-73.0%) | -$218.14M(-54.0%) |
| Dec 2011 | -$141.68M(-247.1%) | -$50.32M(-7.7%) | -$141.68M(-6.5%) |
| Sep 2011 | - | -$46.73M(-37.3%) | -$133.06M(-279.0%) |
| Jun 2011 | - | -$34.05M(-221.8%) | $74.34M(-22.4%) |
| Mar 2011 | - | -$10.58M(+74.6%) | $95.77M(-0.6%) |
| Dec 2010 | $96.34M(+233.4%) | -$41.70M(-126.0%) | $96.34M(+5.1%) |
| Sep 2010 | - | $160.67M(+1372.6%) | $91.64M(+216.2%) |
| Jun 2010 | - | -$12.63M(-26.2%) | -$78.85M(-18.0%) |
| Mar 2010 | - | -$10.00M(+78.4%) | -$66.85M(+7.4%) |
| Dec 2009 | -$72.23M(+18.9%) | -$46.40M(-372.4%) | -$72.23M(-17.1%) |
| Sep 2009 | - | -$9.82M(-1476.6%) | -$61.67M(+34.0%) |
| Jun 2009 | - | -$623.00K(+95.9%) | -$93.39M(-7.9%) |
| Mar 2009 | - | -$15.38M(+57.1%) | -$86.57M(+2.8%) |
| Dec 2008 | -$89.09M | -$35.84M(+13.7%) | -$89.09M(-3567.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2008 | - | -$41.55M(-770.4%) | -$2.43M(-108.5%) |
| Jun 2008 | - | $6.20M(+134.6%) | $28.42M(+51.9%) |
| Mar 2008 | - | -$17.90M(-135.2%) | $18.71M(-31.6%) |
| Dec 2007 | $27.37M(+18.6%) | $50.82M(+574.9%) | $27.37M(-8.3%) |
| Sep 2007 | - | -$10.70M(-205.1%) | $29.86M(+16.1%) |
| Jun 2007 | - | -$3.51M(+62.0%) | $25.73M(+200.6%) |
| Mar 2007 | - | -$9.24M(-117.3%) | $8.56M(-62.9%) |
| Dec 2006 | $23.07M(+176.2%) | $53.30M(+459.4%) | $23.07M(+146.1%) |
| Sep 2006 | - | -$14.83M(+28.3%) | -$50.08M(+0.3%) |
| Jun 2006 | - | -$20.68M(-491.7%) | -$50.24M(+13.6%) |
| Mar 2006 | - | $5.28M(+126.6%) | -$58.15M(-91.9%) |
| Dec 2005 | -$30.30M(-79.2%) | -$19.85M(-32.3%) | -$30.30M(-33.8%) |
| Sep 2005 | - | -$15.00M(+47.5%) | -$22.65M(-101.6%) |
| Jun 2005 | - | -$28.58M(-186.3%) | -$11.24M(-132.3%) |
| Mar 2005 | - | $33.13M(+371.6%) | $34.80M(+305.8%) |
| Dec 2004 | -$16.91M(-175.7%) | -$12.20M(-240.2%) | -$16.91M(+49.0%) |
| Sep 2004 | - | -$3.59M(-120.5%) | -$33.14M(-202.7%) |
| Jun 2004 | - | $17.46M(+194.0%) | $32.26M(+224.5%) |
| Mar 2004 | - | -$18.58M(+34.6%) | -$25.91M(-322.4%) |
| Dec 2003 | -$6.13M(+94.5%) | -$28.43M(-146.0%) | -$6.13M(+29.7%) |
| Sep 2003 | - | $61.81M(+251.8%) | -$8.73M(+90.8%) |
| Jun 2003 | - | -$40.71M(-3512.2%) | -$94.39M(-13.4%) |
| Mar 2003 | - | $1.19M(+103.8%) | -$83.28M(+24.7%) |
| Dec 2002 | -$110.52M(-92.8%) | -$31.03M(-30.1%) | -$110.52M(-13.8%) |
| Sep 2002 | - | -$23.85M(+19.4%) | -$97.15M(-2.1%) |
| Jun 2002 | - | -$29.59M(-13.6%) | -$95.19M(-27.0%) |
| Mar 2002 | - | -$26.05M(-47.6%) | -$74.98M(-30.8%) |
| Dec 2001 | -$57.32M(-105.4%) | -$17.65M(+19.4%) | -$57.32M(-32.0%) |
| Sep 2001 | - | -$21.89M(-133.4%) | -$43.44M(-68.7%) |
| Jun 2001 | - | -$9.38M(-11.7%) | -$25.75M(-30.6%) |
| Mar 2001 | - | -$8.40M(-122.7%) | -$19.72M(+29.3%) |
| Dec 2000 | -$27.91M(-101.7%) | -$3.77M(+10.3%) | -$27.91M(-62.4%) |
| Sep 2000 | - | -$4.20M(-25.5%) | -$17.18M(+16.8%) |
| Jun 2000 | - | -$3.35M(+79.8%) | -$20.65M(+6.1%) |
| Mar 2000 | - | -$16.59M(-338.4%) | -$22.00M(-59.0%) |
| Dec 1999 | -$13.84M(-35.6%) | $6.96M(+190.7%) | -$13.84M(+47.8%) |
| Sep 1999 | - | -$7.67M(-63.6%) | -$26.50M(-81.2%) |
| Jun 1999 | - | -$4.69M(+44.3%) | -$14.62M(-1.4%) |
| Mar 1999 | - | -$8.43M(-47.8%) | -$14.42M(-41.4%) |
| Dec 1998 | -$10.20M(-67.8%) | -$5.70M(-235.9%) | -$10.20M(-628.2%) |
| Sep 1998 | - | $4.20M(+193.4%) | -$1.40M(+80.8%) |
| Jun 1998 | - | -$4.49M(-6.8%) | -$7.30M(-5.7%) |
| Mar 1998 | - | -$4.21M(-235.7%) | -$6.91M(-13.2%) |
| Dec 1997 | -$6.08M(+70.0%) | $3.10M(+282.4%) | -$6.10M(+34.4%) |
| Sep 1997 | - | -$1.70M(+58.5%) | -$9.30M(+36.3%) |
| Jun 1997 | - | -$4.10M(-20.6%) | -$14.60M(+11.0%) |
| Mar 1997 | - | -$3.40M(-3300.0%) | -$16.40M(+19.2%) |
| Dec 1996 | -$20.28M(-321.1%) | -$100.00K(+98.6%) | -$20.30M(-12.2%) |
| Sep 1996 | - | -$7.00M(-18.6%) | -$18.10M(+19.2%) |
| Jun 1996 | - | -$5.90M(+19.2%) | -$22.40M(-18.5%) |
| Mar 1996 | - | -$7.30M(-447.6%) | -$18.90M(-3.8%) |
| Dec 1995 | -$4.82M(+48.2%) | $2.10M(+118.6%) | -$18.20M(+42.6%) |
| Sep 1995 | - | -$11.30M(-370.8%) | -$31.70M(-20.5%) |
| Jun 1995 | - | -$2.40M(+63.6%) | -$26.30M(-45.3%) |
| Mar 1995 | - | -$6.60M(+42.1%) | -$18.10M(+11.7%) |
| Dec 1994 | -$9.30M(+69.1%) | -$11.40M(-93.2%) | -$20.50M(-13.3%) |
| Sep 1994 | - | -$5.90M(-201.7%) | -$18.10M(+0.5%) |
| Jun 1994 | - | $5.80M(+164.4%) | -$18.20M(+42.8%) |
| Mar 1994 | - | -$9.00M(0.0%) | -$31.80M(-5.6%) |
| Dec 1993 | -$30.14M(-75.5%) | -$9.00M(-50.0%) | -$30.10M(-11.1%) |
| Sep 1993 | - | -$6.00M(+23.1%) | -$27.10M(-8.8%) |
| Jun 1993 | - | -$7.80M(-6.8%) | -$24.90M(-16.9%) |
| Mar 1993 | - | -$7.30M(-21.7%) | -$21.30M(-23.8%) |
| Dec 1992 | -$17.17M(-152.1%) | -$6.00M(-57.9%) | -$17.20M(-53.6%) |
| Sep 1992 | - | -$3.80M(+9.5%) | -$11.20M(-51.4%) |
| Jun 1992 | - | -$4.20M(-31.3%) | -$7.40M(-131.3%) |
| Mar 1992 | - | -$3.20M | -$3.20M |
| Dec 1991 | -$6.81M | - | - |
FAQ
- What is Regeneron Pharmaceuticals, Inc. annual cash from operations?
- What is the all-time high annual cash from operations for Regeneron Pharmaceuticals, Inc.?
- What is Regeneron Pharmaceuticals, Inc. annual cash from operations year-on-year change?
- What is Regeneron Pharmaceuticals, Inc. quarterly cash from operations?
- What is the all-time high quarterly cash from operations for Regeneron Pharmaceuticals, Inc.?
- What is Regeneron Pharmaceuticals, Inc. quarterly cash from operations year-on-year change?
- What is Regeneron Pharmaceuticals, Inc. TTM cash from operations?
- What is the all-time high TTM cash from operations for Regeneron Pharmaceuticals, Inc.?
- What is Regeneron Pharmaceuticals, Inc. TTM cash from operations year-on-year change?
What is Regeneron Pharmaceuticals, Inc. annual cash from operations?
The current annual cash from operations of REGN is $4.42B
What is the all-time high annual cash from operations for Regeneron Pharmaceuticals, Inc.?
Regeneron Pharmaceuticals, Inc. all-time high annual cash from operations is $7.08B
What is Regeneron Pharmaceuticals, Inc. annual cash from operations year-on-year change?
Over the past year, REGN annual cash from operations has changed by -$173.50M (-3.78%)
What is Regeneron Pharmaceuticals, Inc. quarterly cash from operations?
The current quarterly cash from operations of REGN is $1.14B
What is the all-time high quarterly cash from operations for Regeneron Pharmaceuticals, Inc.?
Regeneron Pharmaceuticals, Inc. all-time high quarterly cash from operations is $3.41B
What is Regeneron Pharmaceuticals, Inc. quarterly cash from operations year-on-year change?
Over the past year, REGN quarterly cash from operations has changed by +$790.40M (+223.28%)
What is Regeneron Pharmaceuticals, Inc. TTM cash from operations?
The current TTM cash from operations of REGN is $4.74B
What is the all-time high TTM cash from operations for Regeneron Pharmaceuticals, Inc.?
Regeneron Pharmaceuticals, Inc. all-time high TTM cash from operations is $8.51B
What is Regeneron Pharmaceuticals, Inc. TTM cash from operations year-on-year change?
Over the past year, REGN TTM cash from operations has changed by +$673.00M (+16.53%)